Hanley GE, et al. - Researchers investigated if physician visits for menopause and filling a prescription for hormone replacement therapy differ among women undergoing opportunistic salpingectomy in the population of British Columbia, Canada. Among women (50 years of age and younger) who underwent opportunistic salpingectomy between 2008 and 2014 in British Columbia, women undergoing opportunistic salpingectomy at hysterectomy were compared with women undergoing hysterectomy alone and women undergoing opportunistic salpingectomy for sterilization were compared with women undergoing tubal ligation. Inclusion of 41,413 women was done; of these, 6,861 women underwent hysterectomy alone, 6,500 underwent hysterectomy with opportunistic salpingectomy, 4,479 underwent hysterectomy with bilateral salpingo-oophorectomy, 18,621 underwent tubal ligation and 4,952 women underwent opportunistic salpingectomy for sterilization. The analysis yielded no evidence of an earlier age of onset of menopause among the population of women undergoing hysterectomy with opportunistic salpingectomy and opportunistic salpingectomy for sterilization as measured by physician visits for menopause and initiation of hormone replacement therapy. These outcomes are reassuring, given that earlier age at menopause is linked with raised mortality, especially from cardiovascular disease.